Literature DB >> 19532085

Recurrent bacterial vaginosis.

Phillip Hay1.   

Abstract

PURPOSE OF REVIEW: Bacterial vaginosis is a common condition that recurs frequently, adversely affecting women's lives, and is associated with complications including increased risk of sexually transmitted infections, HIV, and adverse pregnancy outcome. RECENT
FINDINGS: New molecular techniques have increased our understanding of the numerous bacteria associated with bacterial vaginosis, and a biofilm containing mostly Gardnerella and Atopobium vaginae, which can persist after treatment has been described. Suppressive treatment with metronidazole gel can suppress recurrence. Physiological approaches such as acidification and probiotics have been investigated with variable results.
SUMMARY: Advances in our understanding of the pathogenesis of bacterial vaginosis allow the opportunity to improve treatments to prevent recurrence, which may require a combination of modalities. We must find ways to help affected women and reduce the complications associated with bacterial vaginosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19532085     DOI: 10.1097/QCO.0b013e32832180c6

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  16 in total

1.  Prognostic Indicators of Recurrence of Bacterial Vaginosis.

Authors:  Jack D Sobel; Navkiranjot Kaur; Nicole A Woznicki; Dina Boikov; Tina Aguin; Gurveer Gill; Robert A Akins
Journal:  J Clin Microbiol       Date:  2019-04-26       Impact factor: 5.948

2.  Novel PCR-based methods enhance characterization of vaginal microbiota in a bacterial vaginosis patient before and after treatment.

Authors:  Janet A Lambert; Apoorv Kalra; Cristina T Dodge; Susan John; Jack D Sobel; Robert A Akins
Journal:  Appl Environ Microbiol       Date:  2013-04-26       Impact factor: 4.792

3.  Co-occurrence of Trichomonas vaginalis and bacterial vaginosis among HIV-positive women.

Authors:  Megan Gatski; David H Martin; Rebecca A Clark; Emily Harville; Norine Schmidt; Patricia Kissinger
Journal:  Sex Transm Dis       Date:  2011-03       Impact factor: 2.830

4.  Antibacterial treatment of bacterial vaginosis: current and emerging therapies.

Authors:  Jean-Pierre Menard
Journal:  Int J Womens Health       Date:  2011-08-23

Review 5.  Bacterial vaginosis, Atopobium vaginae and nifuratel.

Authors:  Franco Polatti
Journal:  Curr Clin Pharmacol       Date:  2012-02-01

6.  Alcohol use, mycoplasma genitalium, and other STIs associated With HIV incidence among women at high risk in Kampala, Uganda.

Authors:  Judith Vandepitte; Helen A Weiss; Justine Bukenya; Susan Nakubulwa; Yunia Mayanja; Godfrey Matovu; Nassim Kyakuwa; Peter Hughes; Richard Hayes; Heiner Grosskurth
Journal:  J Acquir Immune Defic Syndr       Date:  2013-01-01       Impact factor: 3.731

7.  Rationale and Safety Assessment of a Novel Intravaginal Drug-Delivery System with Sustained DL-Lactic Acid Release, Intended for Long-Term Protection of the Vaginal Microbiome.

Authors:  Hans Verstraelen; Chris Vervaet; Jean-Paul Remon
Journal:  PLoS One       Date:  2016-04-19       Impact factor: 3.240

Review 8.  Use of locally delivered dequalinium chloride in the treatment of vaginal infections: a review.

Authors:  Werner Mendling; Ernst Rainer Weissenbacher; Stefan Gerber; Valdas Prasauskas; Philipp Grob
Journal:  Arch Gynecol Obstet       Date:  2015-10-27       Impact factor: 2.344

9.  Supplementation of standard antibiotic therapy with oral probiotics for bacterial vaginosis and aerobic vaginitis: a randomised, double-blind, placebo-controlled trial.

Authors:  Piotr B Heczko; Anna Tomusiak; Paweł Adamski; Artur J Jakimiuk; Grzegorz Stefański; Aleksandra Mikołajczyk-Cichońska; Magdalena Suda-Szczurek; Magdalena Strus
Journal:  BMC Womens Health       Date:  2015-12-03       Impact factor: 2.809

10.  Predictive value of the composition of the vaginal microbiota in bacterial vaginosis, a dynamic study to identify recurrence-related flora.

Authors:  Bingbing Xiao; Xiaoxi Niu; Na Han; Ben Wang; Pengcheng Du; Risu Na; Chen Chen; Qinping Liao
Journal:  Sci Rep       Date:  2016-06-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.